Free. Unsubscribe any time.
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. filed 31 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 64 transactions and 416,718 shares. None carries the SEC's AFF10B5ONE flag; all 31 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-03, came 29 days after the one before it (2026-08-05) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 5,545 shares, 1,631 fewer than the 7,176 in the filing before it.
- Its 31 plan statements rank 195th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 31 filings on file run from 2025-05-05 to 2026-09-03, and state 7 plan adoption dates, from 2024-12-11 to 2025-11-19.
Trades in Stoke Therapeutics, Inc. 64
- Ticho Barry — 2025-05-01 · S · 3,841 shares
- Ticho Barry — 2025-05-02 · S · 22,790 shares
- Ticho Barry — 2025-06-02 · S · 1,745 shares
- Ticho Barry — 2025-06-03 · S · 6,471 shares
- Ticho Barry — 2025-07-01 · S · 4,503 shares
- Ticho Barry — 2025-08-01 · S · 4,504 shares
- Allan Jonathan — 2025-08-13 · S · 13,712 shares
- Allan Jonathan — 2025-08-29 · S · 850 shares
- Kaye Edward M. MD — 2025-08-29 · S · 1,029 shares
- Allan Jonathan — 2025-09-02 · S · 14,922 shares
- Kaye Edward M. MD — 2025-09-02 · S · 14,860 shares
- Ticho Barry — 2025-09-02 · S · 5,501 shares
Adoption dates in Stoke Therapeutics, Inc. 7
- 2024-12-11 — stated in 8 filings
- 2024-12-12 — stated in 5 filings
- 2024-12-30 — stated in 4 filings
- 2025-08-15 — stated in 5 filings
- 2025-11-10 — stated in 1 filing
- 2025-11-12 — stated in 1 filing
- 2025-11-19 — stated in 7 filings
Results prints in Stoke Therapeutics, Inc. 7
- 2025-03-18
- 2025-05-13
- 2025-08-12
- 2025-11-04
- 2026-01-12
- 2026-05-07
- 2026-08-03
Trades before a print in Stoke Therapeutics, Inc. 6
- 0 days before the 2026-08-03 print — 2026-08-03 · S · Ticho Barry · 5,907 shares
- 0 days before the 2026-08-03 print — 2026-08-03 · S · Ticho Barry · 1,269 shares
- 1 day before the 2025-11-04 print — 2025-11-03 · S · Ticho Barry · 3,776 shares
- 1 day before the 2025-11-04 print — 2025-11-03 · S · Ticho Barry · 1,455 shares
- 1 day before the 2025-11-04 print — 2025-11-03 · S · Ticho Barry · 600 shares
- 1 day before the 2025-11-04 print — 2025-11-03 · S · Ticho Barry · 100 shares
- 6 days before the 2026-05-07 print — 2026-05-01 · S · Ticho Barry · 2,243 shares
- 11 days before the 2025-05-13 print — 2025-05-02 · S · Ticho Barry · 22,790 shares
- 11 days before the 2025-08-12 print — 2025-08-01 · S · Ticho Barry · 4,504 shares
- 12 days before the 2025-05-13 print — 2025-05-01 · S · Ticho Barry · 3,841 shares
- 27 days before the 2025-11-04 print — 2025-10-08 · S · Kaye Edward M. MD · 25,000 shares
- 32 days before the 2025-11-04 print — 2025-10-03 · S · Allan Jonathan · 10,000 shares
Interval to Stoke Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 6within 5 days
- 7within 10 days
- 0shortest, days
- 2no later print
- Ticho Barry 2025-11-03 · S · 1 day before the 2025-11-04 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2025-11-03 · S · 1 day before the 2025-11-04 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2025-11-03 · S · 1 day before the 2025-11-04 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2025-11-03 · S · 1 day before the 2025-11-04 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2026-05-01 · S · 6 days before the 2026-05-07 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2026-08-03 · S · 0 days before the 2026-08-03 print · CHIEF MEDICAL OFFICER
- Ticho Barry 2026-08-03 · S · 0 days before the 2026-08-03 print · CHIEF MEDICAL OFFICER
Adoption dates Stoke Therapeutics, Inc. states
- 2024-12-11 in 8 filings
- 2024-12-12 in 5 filings
- 2024-12-30 in 4 filings
- 2025-08-15 in 5 filings
- 2025-11-10 in 1 filing
- 2025-11-12 in 1 filing
- 2025-11-19 in 7 filings
Filing text: “10b5-1 trading plan adopted by the reporting person on November 12, 2025”
Reported results dates on file
- 2025-03-18
- 2025-05-13
- 2025-08-12
- 2025-11-04
- 2026-01-12
- 2026-05-07
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.